|Date||Title and Summary||Additional Formats|
|Toggle Summary||Dynavax Initiates Phase II Clinical Trial of ISS Vacine for Hepatitis B - Study Focuses on Single-Injection Approach||
|Toggle Summary||Dynavax Names William J. Dawson Vice President, Finance and Operations, and Chief Financial Officer||
|Toggle Summary||Dynavax Raises $34.8 Million In Private Equity Round Led By Care Capital||
|Toggle Summary||Dynavax Names New Vice Presidents||
©2018 Dynavax Technologies Corporation. All rights reserved.